Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Acorda Therapeutics, Inc. (NQ: ACOR)
32.08 USD  -0.32 (-0.99%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Acorda Therapeutics, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and Pharmacyclics, Inc.
May 17, 2012
from Marketwired News Releases
Acorda Therapeutics Reports First Quarter 2012 Financial Results
May 03, 2012
from Business Wire News Releases
Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Second Consecutive Year
April 30, 2012
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2012 Financial Results on May 3, 2012
April 26, 2012
from Business Wire News Releases
Acorda Therapeutics Presents AMPYRA® Long-Term Safety and Efficacy Data at 64th American Academy of Neurology Annual Meeting
April 25, 2012
from Business Wire News Releases
New Data Presented at 64th AAN Annual Meeting Highlights Biogen Idec’s Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases
April 20, 2012
from Business Wire News Releases
Acorda Therapeutics Named One of the 100 Most Trustworthy Companies by Forbes
April 12, 2012
from Business Wire News Releases
Acorda Therapeutics to Provide Pipeline Update at Upcoming R&D Day
April 10, 2012
from Business Wire News Releases
Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampyra® (Dalfampridine) of Walking Problems in Patients with Multiple Sclerosis
April 02, 2012
from Business Wire News Releases
Acorda Therapeutics to Present at the Cowen & Company 32nd Annual Health Care Conference
February 27, 2012
from Business Wire News Releases
Acorda Therapeutics to Present at 2012 RBC Capital Markets' Global Healthcare Conference
February 22, 2012
from Business Wire News Releases
Acorda Therapeutics to Present at Citi 2012 Global Health Care Conference
February 21, 2012
from Business Wire News Releases
Acorda Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results
February 16, 2012
from Business Wire News Releases
A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories
February 09, 2012
from Marketwired News Releases
Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference
February 09, 2012
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
February 09, 2012
from Business Wire News Releases
Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference
February 07, 2012
from Business Wire News Releases
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES®
February 06, 2012
from Business Wire News Releases
Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke
February 03, 2012
from Business Wire News Releases
Acorda Therapeutics Provides 2012 Corporate Update at 30th Annual J.P. Morgan Healthcare Conference
January 09, 2012
from Business Wire News Releases
Acorda Therapeutics to Present at the 30th Annual J.P. Morgan Healthcare Conference
December 28, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the Piper Jaffray 23rd Annual Healthcare Conference
November 22, 2011
from Business Wire News Releases
Acorda Therapeutics Announces Preclinical Data on GGF2 in Heart Failure Presented at American Heart Association Scientific Sessions 2011
November 16, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
November 08, 2011
from Business Wire News Releases
Professional Outlook, Will EU's Deal Hold the Markets? - Equity Research on Acorda Therapeutics Inc. and BioMarin Pharmaceutical Inc.
November 07, 2011
from Marketwired News Releases
Acorda Therapeutics Reports Third Quarter 2011 Financial Results
November 04, 2011
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Discuss Third Quarter 2011 Financial Results on November 4, 2011
October 27, 2011
from Business Wire News Releases
Acorda Therapeutics Announces Data on AMPYRA® Presented at 5th Joint Triennial Congress of ECTRIMS and ACTRIMS
October 21, 2011
from Business Wire News Releases
Survey Finds Majority of People With Multiple Sclerosis Report Difficulty Walking or Maintaining Balance
October 20, 2011
People with MS who report difficulty walking find it is the most challenging aspect of managing the disease, restricting daily activities and affecting emotional and financial well-being, according to... Read More
from PR Newswire
Data Presented at the 5th Joint Triennial Congress of ECTRIMS and ACTRIMS Demonstrates Biogen Idec’s Novel Science and Commitment to MS Patients
October 12, 2011
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here